Semax
ACTH 4-10 heptapeptide analog
A Russian-developed nootropic peptide studied for attention, memory consolidation and stroke recovery.
How it works
Raises BDNF and NGF expression in the hippocampus and modulates dopaminergic and serotonergic tone, without the corticotropic activity of full ACTH.
What research has shown
Russian stroke and cognitive studies report improved recovery scores and attention measures; Western replication is limited.
Reported ranges in the literature
Low end
200 mcg daily intranasal
Optimal
300 to 600 mcg daily
High end
900 mcg daily in reported protocols
Frequency reported in the literature: Daily in 10 to 14 day courses
Protocol duration and pairing
Typical study duration
10 to 30 day courses in the Russian clinical literature.
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.